Intended for healthcare professionals

Opinion

If we want to take prevention of multiple long term conditions seriously, then we need to know what we mean by that

BMJ 2025; 388 doi: https://doi.org/10.1136/bmj.q2821 (Published 20 February 2025) Cite this as: BMJ 2025;388:q2821
  1. Simon DS Fraser, professor of public health12,
  2. Nisreen A Alwan, professor of public health12
  1. 1School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
  2. 2University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

The prevention of multiple long term conditions needs to be higher up the healthcare agenda and for this to happen we need to be more precise about what we mean when talking about it.

As populations globally age and the prevalence of multiple long term conditions increases, prevention needs to become a much more central component of strategies mitigating their impact on health systems and individuals.123 Health and care systems will not be sustainable without these strategies.

We need to think about prevention of both the incidence and the impact of multiple long term conditions, and prevention strategies need to be equitable, given the well documented demographic and socioeconomic inequalities in the prevalence of multiple long term conditions.4

But this is easier said than done, not least because we haven’t really got to grips with what we mean by prevention for multiple long term conditions. Traditional concepts of primary, secondary, and tertiary prevention sit uneasily in the context of multiple long term conditions, but we will need specificity to make prevention work on the ground.

As a brief reminder of definitions: primary prevention usually refers to activities which reduce the risk of a disease occurring or manifesting (i.e. “incident” cases’). Secondary prevention aims to detect disease and deal with it early enough to improve health outcomes.56 Tertiary prevention aims to reduce the impact of ill-health that has ongoing, long term effects.6 Primordial prevention aims to reduce the “ emergence and establishment of environmental, economic, and social conditions that are known to increase the risk of disease.”6

Now let us try to apply these in the context of multiple long term conditions:

Primary prevention

For most people with multiple long term conditions, the accrual of long term conditions happens across their lives. So prevention could be aimed at the “sentinel condition” (defined as the first long term condition which occurs in the process of developing multiple long term conditions) 7 by tackling its risk factors. This could be considered true primary prevention as it aims to stop the accrual of long term conditions right at the beginning.

However, the wide range of sentinel conditions makes this a little problematic. Some of them can be precursors for others e.g., hypertension and cerebrovascular disease, and some are not preventable in the traditional sense e.g., genetic disorders. So even if we could prevent that first condition, it would not eliminate all multiple long term conditions.

Secondary prevention

The early detection of sentinel conditions or one or more of the components of multiple long term conditions e.g. through screening programmes or primary care health checks can be considered secondary prevention. This approach can help mitigate some of the impact, as well as providing opportunities for reducing the risk of further long term conditions.

But if what we mean by “prevention” is not being in the situation of having multiple long term conditions, then “primary prevention” of multiple long term conditions could encompass anything that leads to having more than one long term condition, so would include all secondary prevention activities for any sentinel long term condition.

Similarly, prevention of adverse outcomes of multiple long term conditions could be considered secondary prevention, but cannot be pinned down to one set of actions given the high number of potential combinations of long term conditions and outcomes. A strategy based on this will be too vague and we might get confused with tertiary prevention depending on the type of health outcomes considered.

Tertiary prevention

If we focus on prevention of the impact or ongoing “burden” to individuals of living with multiple long term conditions, this could be considered tertiary prevention. However, the nature of the impact varies widely by the condition combination experienced by an individual, and it could even be considered primary prevention of the state of being “burdened.”8

Primordial prevention

Prevention tackling the wider social, economic, and environmental modifiable determinants of health, including “the determinants of the determinants” can be considered primordial prevention.9 This includes activity across the lifecourse, but particularly in early life, at population level, to reduce life chances of developing any long term condition and therefore multiple long term conditions.

What next?

We clearly need a better language or framework for the prevention of multiple long term conditions to know where our priorities should lie, particularly in the context of limited resources and overwhelmed health systems.10

As Geoffrey Rose recognised in his 1981 article on strategies of prevention there is a paradox in taking just a “high risk” approach to health care. You may think you are doing the right thing, and be striving hard to achieve it, but “a large number of people exposed to a low risk is likely to produce more cases than a small number of people exposed to a high risk.”11

Taking a “high-risk” approach to the prevention of multiple long term conditions might focus all our endeavours on “secondary and tertiary prevention” i.e. screening for the first long term condition and reducing the risk of subsequent long term conditions and of adverse outcomes. While vitally important activities, these will not stop the ever-increasing population of people developing multiple long term conditions and the consequent impact on individuals and health systems.

The risk of developing long term conditions starts early in life and prevention policies and strategies need to adequately reflect that in both their focus and scale of endeavour through primary and primordial whole-population prevention approaches.

For example, a long term strategy to prevent the multiple long term condition combination of chronic kidney disease, hypertension, type 2 diabetes, depression and obesity should not only consider mid or later life pathways such as those from obesity to diabetes and hypertension, and from diabetes to chronic kidney disease and depression, but also early lifecourse determinants and risk factors for childhood obesity, adolescent mental health problems, and early-onset hypertension.

However, as people’s lives are lengthened by better living conditions and health care, we also need more attention given to tackling the impact of living with multiple long term conditions where quality of life is prioritised and the “workload” of living with multiple long term conditions is reduced as much and for as long as possible.8

According to Head and colleagues “the focus on multimorbidity must shift from solely management of high-risk older individuals to include integrated population-level prevention strategies throughout the life-course to address the drivers of multimorbidity.”2 We agree with this. But we also argue for an urgent need to be more specific when talking about the prevention of multiple long term conditions.

Our call for action is to:

a) achieve consensus among experts and those with lived experience towards a widely adopted and easily understood multiple long term conditions prevention framework

b) incorporate the whole lifecourse when considering prevention of multiple long term conditions

c) integrate all types of prevention (primordial, primary, secondary and tertiary) within such lifecourse framework.

Footnotes

  • Competing interests: SDSF and NAA are investigators on the NIHR-supported Multidisciplinary Ecosystem to study Lifecourse Determinants and Prevention of Early-onset Burdensome Multimorbidity (MELD-B).

  • Provenance and peer review: not commissioned, not externally peer reviewed.

References